This, second part of the study, was based on results of previous publication reporting that sera of some of multiple myeloma (MM) patients showed the presence of elevated levels of anti-gliadin IgA- without the enhanced levels of anti-gliadin IgG immunoglobulins, determined on commercial ELISA test. This evidence concerns the gene CD79A and Miyoshi myopathy.